Art
J-GLOBAL ID:201502269066247439   Reference number:15A0303225

EBM-based Clinical Guidelines for Pancreatic Cancer (2013): perspectives on chemotherapy

膵癌診療ガイドライン2013からみた膵癌化学療法の展望
Author (11):
Material:
Volume: 29  Issue:Page: 892-897 (J-STAGE)  Publication year: 2014 
JST Material Number: X0203A  ISSN: 0913-0071  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0303225&from=J-GLOBAL&jstjournalNo=X0203A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of digestive system  ,  Drug therapy(=pharmacotherapy)for tumors 
Reference (11):
  • 1) 日本膵臓学会膵癌診療ガイドライン改訂委員会編. 科学的根拠に基づく膵癌診療ガイドライン2013年版. 第3版. 東京: 金原出版, 2013.
  • 2) Uesaka K, Fukutomi A, Boku N, et al. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for resected pancreatic cancer patients (JASPAC-01 study). 2013 Gastrointestinal Cancers Symposium. 2013; abstr 105691.
  • 3) Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297: 267-77.
  • 4) Ueno H, Kosuge T, Matsuyama Y, et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009; 101: 908-15.
  • 5) Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960-6.
more...
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page